Transgene (Production Asset)

Transgene (Production Asset) Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

Transgene (Production Asset) General Information

Description

Production unit in Strasbourg, France. The unit is designed and equipped to manufacture clinical lots of pharmaceuticals and vaccines using viral vectors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
ABL (US)
Primary Office
  • Strasbourg
  • France
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Transgene (Production Asset) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Transgene (Production Asset)‘s full profile, request access.

Request a free trial

Transgene (Production Asset) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Transgene (Production Asset)‘s full profile, request access.

Request a free trial